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Fifteen years ago, the generation of new neurons in adulthood was documented in the human hip-
pocampus, but lingering questions have remained about the extent of this process. In this issue of
Cell, Spalding et al. provide elegant evidence for continued neurogenesis into adulthood at rates
that suggest it may play a significant role in human behavior.For most of the 20th century, neuroscien-
tists thought that the adult mammalian
brain did not generate new neurons.
Evidence that this wasn’t the case was
reported (Altman and Das, 1965), but
only in the 1990s did sufficient data accu-
mulate for the field to accept that adult
neurogenesis did occur in mammals.
Now, it is well established that, in rodents,
the olfactory bulb and the dentate gyrus
(DG) region of the hippocampus incorpo-
rate new neurons in adulthood. However,
in nonhuman primates, lower levels of
adult neurogenesis were observed. These
data, despite evidence that neurogenesis
does occur in the adult human DG (Eriks-
son et al., 1998), caused considerable
anxiety in the field. When it comes to
the relevance of adult neurogenesis in
humans, two questions have remained:
to what extent does this process occur
in our species and can a small number
of cells generated in the adult hippo-
campus impact human behavior? In this
issue of Cell, Spalding et al. (2013) have
answered the first question by providing
powerful evidence for extensive neuro-
genesis in humans throughout adulthood
with numbers comparable to those seen
in rodents.
In 2005, Spalding and Frise´n took the
concepts underlying radiocarbon-dating
techniques used in archaeology and
developed an ingenious strategy for
birth-dating cells from postmortem tissue
(Spalding et al., 2005). The technique is
based on the pronounced spike in global
levels of 14C that resulted from extensiveabove-ground nuclear weapon testing
during the Cold War and the fact that
there has been a steady decline in atmo-
spheric 14C since such testing was
banned. Because plants absorb 14C via
CO2 during photosynthesis, animals that
eat them also take in radioactive carbon;
therefore, the 14C level in our bodies
reflects that of the atmosphere. Conse-
quently, when a cell divides, newly syn-
thesized DNA integrates a trace amount
of 14C that is proportional to the environ-
mental level at the time of mitosis; hence,
the radioactivity of a cell nucleus can be
used as a time stamp of the cell’s genesis.
Using this technique, this group had
previously found that the human olfactory
bulb did not contain neurons born in
adulthood (Bergmann et al., 2012), a result
that is strikingly different than the one
observed in rodents, where olfactory
bulb neurogenesis continues throughout
life. But, in the hippocampus, they found
that neurogenesis occurs at significant
levels through adulthood anduntil old age.
The first surprise from this study was
that, unlike the stark age-related decline
seen in rodents, the human hippocampus
appears to generate new neurons at
a fairly steady rate well into old age
(Figure1). Their computational modeling
studies indicated that their data was
best fit by a scenario in which there was
one population of hippocampal neurons
that did not turn over, whereas 35% of
the neurons did. Given that DG neurons
correspond to roughly 35% of the total
hippocampal population, this suggestsCell 1that a majority of DG cells are subject
to exchange. This is in dramatic contrast
to rodents, where it has been estimated
that neurons generated in adulthood
correspond to only 10% of DG granule
cells (Imayoshi et al., 2008). About
700 neurons are added daily in the
adult human DG, corresponding to an
annual turnover rate of 1.75%, which is
similar to the levels found in middle-
aged rodents.
This study is of profound importance,
given that it will further invigorate the field
for the study of the contribution of adult
hippocampal neurogenesis to human
behavior and mental health. Previous
concerns about low levels of neurogene-
sis in humans and its potentially limited
importance in aged individuals can now
be tempered. For instance, these findings
support the importance of investigating
the therapeutic potential of harnessing
adult neurogenesis for the treatment
of age-related cognitive disorders. In
rodents, adult neurogenesis is involved
in modulating pattern separation, a cog-
nitive process that declines with age
(Sahay et al., 2011). In addition, neuro-
genesis has been implicated in the behav-
ioral effects of antidepressants (Santarelli
et al., 2003) and memory generalization
in anxiety disorders (Kheirbek et al.,
2012), links that can now be investigated
in humans with renewed confidence.
Interestingly, the individuals used in
Spalding et al. (2013) showed significant
variability in levels of incorporated 14C,
which could serve as an opportunity to53, June 6, 2013 ª2013 Elsevier Inc. 1183
Figure 1. Comparative Rates of Adult Neurogenesis in Mice and Men
In contrast to the very low levels of adult neurogenesis reported in the human olfactory bulb (blue line), the
human hippocampus continues to generate neurons at a steady rate well into old age with only a modest
decline throughout adulthood (red line). The rate of neurogenesis in adult humans is comparable to levels
seen in middle-aged rodents (9 months old; intersection of green line and red line). These results suggest
that studies in rodents revealing the role of adult hippocampal neurogenesis in cognitive function (pattern
separation) and emotional behavior (mood/anxiety) may also hold true in adult humans.retrospectively compare levels of hippo-
campal neurogenesis with each individ-
ual’s medical history in order to probe
for a relationship between psychiatric
conditions and rates of cell turnover.
Yet, this remains only the beginning,
because much of our knowledge about
the contribution of hippocampal neuro-
genesis to behavior is derived from rodent
studies, and the significant differences
between rodents and humans in the
neurogenic process remains to be
fleshed out. For example, a recent report
indicated that the maturation process in
nonhuman primates extended up to
6 months, significantly longer than the
month or so it takes in rodents (Kohler
et al., 2011). In addition, in humans, it
has been reported that there exists
regional differences in the neurogenic
effects of antidepressants (Boldrini et al.,
2009). Specifically, the ability of antide-1184 Cell 153, June 6, 2013 ª2013 Elsevier Inpressants to increase neurogenesis in
humans appears to be most pronounced
in the anterior pole of the hippocampus.
Future studies comparing the temporal
and regional rates of neurogenesis be-
tween humans and rodents will provide
essential clues about the contribution
of adult-generated granule cells to DG
physiology and behavior in humans.
The study from Spalding et al. (2013)
also underscores the necessity for
developing methods for imaging human
hippocampal neurogenesis in vivo. Such
methods are still in their infancy but are
a necessary step for understanding how
neurogenesis may change under disease
and treatment conditions.
This landmark study by Spalding et al.
(2013) legitimizes the explosion of
research into the process of adult neuro-
genesis in recent years. The discovery
that the human hippocampus canc.generate new cells at a significant rate
until old age puts to rest concerns about
whether or not this process occurs at
significant rates in people. Moreover, it
will energize efforts to answer the second
question of how this small number of
cells impact human behavior and will
fuel efforts to target this process for the
development of new therapies for the
treatment of disorders of cognition and
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